Tocilizumab
Titre original de l'avis
Belgium – Pharmaceutical products – Raamovereenkomst voor de levering van Tocilizumab
Score d'opportunité
Pourquoi ce score ?
Opportunité
45 / 100
Complexité
40 / 100
Facteurs de risque
The estimated contract value is not disclosed. This makes it hard to evaluate the financial opportunity and bid prepara...
The tender is only in Dutch (NLD). Non-Dutch speaking suppliers may struggle to understand requirements and submit comp...
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Informations clés
- Pouvoir adjudicateur
- Hospilim VZW
- Pays
- Belgique
- CPV
- 33600000 - Pharmaceutical products +2 autres
- Date limite
- Aug 10, 2026
Aperçu
Moderate opportunityFaits clés
- Framework procurement
- Supplies contract
- 1 lot
- Duration 24 MONTH
- Supply of the pharmaceutical product Tocilizumab
- Framework agreement with duration of 24 months (with possibility of up to 120 months as per XML notice)
Afficher le résumé complet
This is an open procedure for a framework agreement for the supply of Tocilizumab (a medicinal product) in Belgium. The tender is managed by Hospilim VZW, a public health undertaking. The contract duration is 24 months (with a possible extension of 120 months indicated in the XML notice). The submission deadline is 2026-08-10T08:00:00 UTC. The tender is not EU-funded according to the XML notice (no-eu-funds), though structured data says EU-funded. Estimated value is not provided. The procurement documents are available online but were not analyzed in detail.
Risques
The estimated contract value is not disclosed. This makes it hard to evaluate the financial opportunity and bid prepara...
The tender is only in Dutch (NLD). Non-Dutch speaking suppliers may struggle to understand requirements and submit comp...
L'analyse peut être incomplète
Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.
Exigences clés
Administrative
- Electronic submission is required
- Tender documents must be accessed via the provided URL
- Language of tender: Dutch (NLD)
Les exigences peuvent être incomplètes.
Critères d'attribution
Lot 1
Acheteur
Nom
Localisation
Diepenbeek, BEL
Site web
Profil acheteur
Identifiant
0833506251_1137
Activité
Health
Lots (1)
LOT-0001
Tocilizumab
Framework agreement for the supply of Tocilizumab. The lot covers pharmaceutical products with CPV codes 33600000, 33690000, and 33652000. Performance is in Belgian subdivisions BE223, BE224, BE225.
Localisation
Durée
Catégorie
Critères d'attribution
Date limite
Détails des critères
Totale netto kost
Farmaceutische kwaliteit en veiligheid
Leverbetrouwbaarheid en dienst na verkoop
Codes CPV supplémentaires
Note sur la valeur
Afficher les données TED originales
Description TED originale
Raamovereenkomst voor de levering van Tocilizumab
Détails de la procédure
- Date de publication
- 25 Jun 2026
- Langues
- Dutch
Métadonnées de référence
- Base juridique
- 32014L0024
Identifiants de référence
- ID de l'appel d'offres
- 441078-2026
Documents (2)
Appels d'offres similaires
Spain – Various medicinal products – Suministro de medicamentos destinado a terapias genicas mediante SDA
Czechia – Specialised chemical products – DNS - chemikálie pro molekulární a buněčnou biologii
Italy – Various medicinal products – Bando V SDA farmaci
Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на КОЦ-Русе ЕООД
Italy – Various medicinal products – ARIA_2025_045
Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на УМБАЛ "Царица Йоанна-ИСУЛ" ЕАД
Score d'opportunité
Pourquoi ce score ?
Opportunité
45 / 100
Complexité
40 / 100
Facteurs de risque
The estimated contract value is not disclosed. This makes it hard to evaluate the financial opportunity and bid prepara...
The tender is only in Dutch (NLD). Non-Dutch speaking suppliers may struggle to understand requirements and submit comp...
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications